West Pharmaceutical Services (WST) Stock Analysis & Winston Score

West Pharmaceutical Services makes the small but critical components used to seal and deliver injectable drugs. Their main products are rubber stoppers, plastic caps, and drug delivery devices — the parts that go on top of vials, syringes, and cartridges. Nearly every major pharmaceutical and biotech company in the world uses West's components to package their medicines safely. West earns revenue by selling these components and systems directly to drug manufacturers on a recurring basis, since every vial produced requires new parts. The company operates globally, with manufacturing facilities across North America, Europe, and Asia, and generates roughly $3 billion in annual revenue. Its moat comes from strict regulatory requirements in the drug industry — once a drug is approved using West's specific components, switching to a competitor requires expensive re-testing and re-approval. The key risk is that a slowdown in injectable drug production, particularly biologics and vaccines, would directly reduce demand for West's products.